Skip to main content
Premium Trial:

Request an Annual Quote

BGI to Use Covaris' High-Throughput DNA Shearing Platform

Premium

China's BGI will adopt Covaris' high-throughput DNA shearing technology at several of its laboratories in China, Covaris said this week.

Under the deal, BGI will use Covaris' LE220 instrument and consumables as part of its library construction process for next-generation sequencing.

The LE220 is designed for high-throughput next-gen sequencing operations. Using Covaris' Adaptive Focused Acoustic, or AFA, technology, it can shear several DNA samples in parallel and accepts a variety of well plate formats.

For example, in a 96-well microplate, the instrument processes a row of eight samples in parallel, according to the firm.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.